| Financial Year |
March 31 2023 |
| Monetary Funds |
378,655,682.33 |
| Held-for-trading Financial Assets |
46,415,216.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
942,087,765.20 |
| Advances to Suppliers |
61,785,157.61 |
| Other Receivables |
83,827,125.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,543,268.94 |
| Inventories |
22,568,242.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
142,926,072.96 |
| Other Current Assets |
169,125,010.11 |
| Total Current Assets |
1,926,035,748.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,318,414,532.48 |
| Long-term Equity Investment |
503,734,565.73 |
| Investment Properties |
-- |
| Fixed Assetes |
9,317,491.87 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,437,353,386.49 |
| R&D expenses |
-- |
| Goodwill |
134,465.98 |
| Long-Term Deferred and Prepaid Expenses |
5,378,364.75 |
| Deferred Income Tax Assets |
14,033,585.48 |
| Other Non-Current Assets |
1,478,429,254.42 |
| Sub-Total of Non-Current Assets |
5,834,539,178.18 |
| Total Assets |
7,760,574,926.78 |
| Short-Term Loans |
53,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,307,316,892.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,880,023.71 |
| Taxes Payable |
102,801,600.63 |
| Interest Payable |
20,466,172.20 |
| Dividend Payable |
3,571,326.20 |
| Other payables |
1,348,389,384.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
415,081,780.97 |
| Other Current Liabilities |
4,927,319.64 |
| Sub-Total of Current Liabilities |
3,404,233,015.13 |
| Long-term Loans |
1,812,809,291.30 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
129,832,644.23 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,455,595,224.69 |
| Total Liabilities |
5,859,828,239.82 |
| Paid-In Capital(Or Share Stock) |
968,495,801.00 |
| Capital Surplus |
1,404,056,544.39 |
| Surplus Reserve |
41,523,865.22 |
| LESS:Treasury Stock |
148,868,626.53 |
| Undistributed Profits |
-579,640,287.13 |
| Minority Stockholder's Interest |
215,720,781.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,685,025,905.48 |
| Owner's Equity（Stockholder's Equity） |
1,900,746,686.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,760,574,926.78 |
